financetom
Business
financetom
/
Business
/
Carvana Insider Sold Shares Worth $939,347, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Carvana Insider Sold Shares Worth $939,347, According to a Recent SEC Filing
Sep 29, 2025 3:08 PM

05:43 PM EDT, 09/29/2025 (MT Newswires) -- Ernest C. Garcia III, 10% Owner, Director, Chief Executive Officer, on September 25, 2025, sold 2,600 shares in Carvana ( CVNA ) for $939,347. Following the Form 4 filing with the SEC, Garcia has control over a total of 1,422,066 Class A common shares of the company, with 921,926 shares held directly and 500,140 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1690820/000170054825000096/xslF345X05/wk-form4_1759181849.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hughes Expands Aviation, Space and Defense Expertise with Strategic Acquisition of Anderson Connectivity
Hughes Expands Aviation, Space and Defense Expertise with Strategic Acquisition of Anderson Connectivity
Oct 22, 2025
GERMANTOWN, Md., Oct. 22, 2025 /PRNewswire/ -- Hughes Network Systems, LLC (HUGHES), an EchoStar company , today announced it has acquired Anderson Connectivity, a leading aerospace innovator in design, engineering, and manufacturing services based in Melbourne, Florida. This acquisition significantly expands Hughes capabilities, adding key technology & engineering talent and product solutions while positioning the company for accelerated growth in the...
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI
Oct 22, 2025
ROCKVILLE, MD / ACCESS Newswire ( ACCS ) / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug discovery has always been its toughest proving ground. Molecules don't follow patterns; they twist, bind, and defy prediction, humbling even the smartest algorithms. That's why Shuttle Pharmaceuticals Holdings ( SHPH ) just made one of the boldest moves...
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Oct 22, 2025
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million. Biossil assumes all further obligations to Blackstone Life Sciences under...
Reckoner Capital launches CLO ETF for BBB rated credits
Reckoner Capital launches CLO ETF for BBB rated credits
Oct 22, 2025
Oct 22 (Reuters) - Reckoner Capital will launch a new exchange-traded fund on Wednesday holding lower credit tiers within the collateralized corporate loan market, in the midst of growing questions about credit quality in the lending market. The new Reckoner BBB-B CLO ETF will make its debut as some of the largest ETFs in the collateralized loan obligation universe witness...
Copyright 2023-2026 - www.financetom.com All Rights Reserved